A comparison of two differing doses of promethazine for the treatment of postoperative nausea and vomiting.

Purpose: To compare the use of promethazine 6.25 mg intravenous (IV) (experimental group) with promethazine 12.5 mg IV (control group) among adult ambulatory surgery patients to control established postoperative nausea or vomiting (PONV).